Login to Your Account



Top-Line Lucentis Data Boost Genentech, Hammer Eyetech

By Aaron Lorenzo


Wednesday, May 25, 2005
Genentech Inc.'s very positive preliminary Lucentis data rippled quickly throughout the industry and sank shares in Eyetech Pharmaceuticals Inc., which sells the already-approved Macugen. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription